In Rare Cases, Diabetes & Cholesterol Drug Combo Could Be Toxic
MONDAY, Aug. 3, 2020 -- Taking the statin Crestor in combination with the diabetes drug canagliflozin (Invokana) may have the potential to trigger statin toxicity, a new case report suggests.
Although this report details the problem in just one...
Source: Drugs.com - Daily MedNews - Category: General Medicine Source Type: news
More News: Canagliflozin | Cholesterol | Crestor | Diabetes | Endocrinology | General Medicine | Invokana | Rosuvastatin | Statin Therapy | Toxicology